Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-27T08:36:00.774Z Has data issue: false hasContentIssue false
  • English
  • Français

The ‘heparin lock’: cause for iatrogenic coagulopathy

Published online by Cambridge University Press:  23 December 2005

M. Vorweg ,
E. Monaca ,
M. Doehn  and
F. Wappler
M. Vorweg
Affiliation:
University of Witten/Herdecke, Department of Anesthesiology, Hospital Cologne-Merheim, Köln, Germany
E. Monaca
Affiliation:
University of Witten/Herdecke, Department of Anesthesiology, Hospital Cologne-Merheim, Köln, Germany
M. Doehn
Affiliation:
University of Witten/Herdecke, Department of Anesthesiology, Hospital Cologne-Merheim, Köln, Germany
F. Wappler
Affiliation:
University of Witten/Herdecke, Department of Anesthesiology, Hospital Cologne-Merheim, Köln, Germany
Get access

Extract

Summary

Background and objective: The reasons for coagulopathy may be multiple and the identification of the underlying cause is often difficult. Recently, we identified two patients showing characteristics of heparin overdose during surgery. We hypothesised that filling a Shaldon dialysis catheter with heparin prior to closure, so-called heparin lock, might have triggered this coagulation disorder. Therefore, the aim of this in vitro study was to show whether this procedure can lead to an iatrogenic administration of heparin. Methods: A Shaldon catheter (GamCath®; Joka Kathetertechnik, Hechingen, Germany) was hung up in a container filled with NaCl solution 0.9% 5 mL and a heparin lock was simulated. Instead of using heparin solution we injected 1 mL of a KCl solution (1 mol L−1) into the Shaldon catheter, because the measurement of the potassium concentration is faster and more reliable than that of heparin. Ten measurements were taken after fast (0.5 s) and slow (3 s) injection speeds. Results: Although the catheter volume is specified as 1.07 mL, an amount up to 0.51 mL KCl solution on average was detectable in the solution after locking the catheter with 1 mL KCl solution. Conclusions: Following a heparin lock a considerable amount of the injected solution is accidentally administered to the patient. Only 49.1% of the injected volume may remain in the Shaldon catheter. This could lead to an increased risk of coagulopathy.

Keywords

HEPARINTHROMBOELASTOGRAPHYRENAL REPLACEMENT THERAPYBLOOD COAGULATION DISORDERS
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 23 , Issue 1 , January 2006 , pp. 50 - 53
Copyright
© 2006 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Karaaslan H, Peyronnet P, Benevent D, Lagarde C, Rince M, Leroux-Robert C. Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis. Nephrol Dial Transplant 2001; 16: 2072–2074.Google Scholar
Moritz ML, Vats A, Ellis D. Systemic anticoagulation and bleeding in children with hemodialysis catheters. Pediatr Nephrol 2003; 18: 68–70.Google Scholar
Meier PC, Ammann D, Osswald HF, Simon W. Review: ion-selective electrodes in clinical chemistry. Med Prog Technol 1977; 15: 1–12.Google Scholar
NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation – Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30 (Suppl 3): 150–191.
Pivalizza EG. Heparinase and thromboelastography in liver transplantation for a patient with von Willebrand's disease. Anesthesiology 1996; 84: 1236–1239.Google Scholar
Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thromboelastography in liver transplantation. Br J Anaesth 1997; 78: 175–179.Google Scholar
Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948; 16: 257–260.Google Scholar
Calatzis AN, Haas S, Gödje O et al. Thromboelastographic coagulation monitoring during cardiovascular surgery with the ROTEG coagulation analyzer. In: Pifarre R, ed. Management of Bleeding in Cardiovascular Surgery. Philadelphia: Hanley & Belfus, 2000: 215–226.
Tuman KJ, McCarthy RJ, Djuric M et al. Evaluation of coagulation during cardiopulmonary bypass with a heparinase modified thromboelastographic assay. J Cardiothorac Vasc Anesth 1994; 8: 144–149.Google Scholar
Despotis GJ, Summerfield AL, Joist JH et al. In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients. Anesth Analg 1994; 79: 670–674.Google Scholar